Wearable Devices Ltd. SEC Filings

Wearable Devices Ltd. has called a special shareholder meeting to vote on a potential reverse split of its ordinary shares at a ratio of up to 4:1. The board would have discretion over whether to implement the split, the exact ratio and the effective date.

The company says the reverse split is intended to support continued listing of its shares on Nasdaq and make the stock more attractive to a broader range of investors. The move would reduce the number of issued and outstanding shares, while leaving authorized capital at 500,000,000 ordinary shares.

The meeting is scheduled for June 4, 2026, with shareholders of record as of May 21, 2026 entitled to vote. A quorum requires holders of at least 25% of outstanding ordinary shares, and approval needs a simple majority of votes cast.

Wearable Devices Ltd. ownership disclosure: Armistice Capital, LLC and Steven Boyd report beneficial ownership of 230,752 ordinary shares, representing 8.00% of the class. The holdings are held by Armistice Capital Master Fund Ltd., for which Armistice Capital acts as investment manager; the Master Fund disclaims beneficial ownership under its Investment Management Agreement.

The filing is a joint Schedule 13G/A amendment signed May 15, 2026, reporting shared voting and dispositive power over the 230,752 shares.

Wearable Devices Ltd. Chief Marketing Officer Barel Shmuel reported an open-market sale of 7,182 Ordinary Shares of the company on May 12, 2026 at $1.00 per share. After this transaction, he continues to hold 24,151 Ordinary Shares directly.

Wearable Devices Ltd. filed a Form 6-K to furnish a press release announcing Mudra Pro, a next-generation wearable neural sensing wristband aimed at advanced AI, XR, and human-machine interaction applications. The device targets product managers, developers, researchers, enterprise innovation teams, OEMs, and technology partners.

Mudra Pro integrates synchronized electromyography (EMG), photoplethysmography (PPG), and inertial measurement unit (IMU) sensors, combined with an ARM Cortex-M33 processor and Bluetooth Low Energy communication, to decode human intent and physiological state. Paired with Mudra Studio and developed within the company’s ai6 Labs initiative, it is intended to support natural interaction, rapid prototyping, and data analytics for spatial computing. The filing also includes a detailed forward-looking statements disclaimer.

Wearable Devices Ltd. registers up to 5,082,873 Ordinary Shares for resale by a selling shareholder; these shares are issuable upon exercise of 5,082,873 New Warrants issued in a private placement. The New Warrants have an exercise price of $1.51 per share and expire five years from issuance.

The company will not receive proceeds from secondary resales by the selling shareholder; the company would receive up to approximately $7.7 million in cash if the New Warrants are exercised in full for cash, assuming exercise in full for cash. Shares outstanding were 6,546,510 as of May 11, 2026; outstanding would be 11,629,383 assuming full cash exercise of all New Warrants.

Wearable Devices Ltd. reports that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a new continuation patent in its “Gesture and Voice-Controlled Interface Device” family. The allowed claims cover a gesture interface device that combines gesture sensors with biopotential sensors to read neural signals and verify users based on personalized gesture signatures.

The technology is designed to enable biometric authentication for secure payments, user detection, and authorization of sensitive actions on the company’s AI‑powered voice‑and‑gesture control platform. Management describes this allowance as strengthening its intellectual property strategy and reinforcing the Mudra platform’s role in AR/VR, enterprise access control, and smart environments.

Wearable Devices Ltd. entered a warrant inducement transaction with an institutional investor, raising approximately $5.0 million in gross cash proceeds through the cash exercise of existing warrants at a reduced price of $1.73 per ordinary share.

In return, the company issued new unregistered warrants to purchase up to 5,082,873 ordinary shares at an exercise price of $1.51 per share, exercisable immediately for five years. The company plans to use the net proceeds for working capital and general corporate purposes and agreed to register the resale of the new warrant shares and observe a 30‑day restriction on additional issuances, new registrations, and variable rate transactions, subject to stated exceptions.

Wearable Devices Ltd. director Bachar Eli filed an initial ownership report showing direct holdings in both ordinary shares and stock options. He reports 37,884 Ordinary Shares held directly, plus stock options over 768 Ordinary Shares at an exercise price of $0.7200 per share expiring on November 27, 2027, and options over 83 Ordinary Shares at an exercise price of $316.8000 per share expiring on November 30, 2033. Footnotes indicate additional equity incentives, including 7,500 Ordinary Shares issuable from 2,500 restricted share units vesting through October 10, 2028, and 28,333 Ordinary Shares issuable from other restricted share units vesting in 34 monthly installments through January 1, 2029.

Wearable Devices Ltd. Chief Executive Officer Asher Dahan filed an initial Form 3, reporting his current equity stake in the company. He directly holds 72,708 Ordinary Shares, reflecting his existing ownership position as of the filing date.

In addition, Dahan holds stock options over 125 Ordinary Shares at an exercise price of $316.80 per share expiring on November 30, 2033, and options over 208 Ordinary Shares at an exercise price of $104.16 per share expiring on September 26, 2034. Footnotes state that his holdings include 6,250 Ordinary Shares issuable upon vesting of RSUs in monthly installments through September 10, 2026, and 47,222 Ordinary Shares issuable upon vesting of RSUs in monthly installments through January 1, 2029, with each RSU representing one Ordinary Share.